Prevalence of β-Lactamase-Encoding Genes among Enterobacteriaceae Bacteremia Isolates Collected in 26 U.S. Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010)
- 1 July 2013
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 57 (7), 3012-3020
- https://doi.org/10.1128/aac.02252-12
Abstract
Enterobacteriaceae bacteremia isolates ( n = 195; 6.4% overall) collected from 26 U.S. hospitals located in 20 states were screened for various β-lactamase classes. A total of 175 isolates carried one to eight acquired β-lactamase genes of 44 types that were detected in 55 combinations. Eighty-five (43.6%) strains carried bla CTX-M , and bla CTX-M-15 was the most prevalent (33.8%). Genes encoding OXA-1/30 (often associated with bla CTX-M-15 ), CMY-2, SHV extended-spectrum β-lactamase (ESBLs), and TEM-1 were also prevalent. Among 33 carbapenem-resistant strains, 28 carried bla KPC-2 or bla KPC-3 (17 and 11 strains, respectively), and those were recovered mostly in the New York City area (16 strains) and Houston, TX (9 strains). Fourteen new SHV variants were identified among Klebsiella pneumoniae isolates carrying one or multiple SHV alleles, three carrying G238S and/or E240K amino acid alterations that confer ESBL activity. Only two of eight K. oxytoca isolates carried acquired β-lactamases, but most had mutations on the bla OXY promoter region, and three new OXY-encoding genes were characterized. Concordance between a commercial nucleic acid-based microarray (Check-MDR CT101) and reference methods was noted for 105/109 (97.2%) strains. Thirty-two strains having genes that are not targeted by the commercial system were detected (OXA ESBLs, PER, PSE, or intrinsic genes). Overall, a great variety of enzymes were observed, with numerous strains carrying multiple genes. Rates of CTX-M-producing strains appear to be increasing in U.S. hospitals (26.6% in 2007 to 43.8% for 2010) participating in the SENTRY Program. Furthermore, the Check-Points system seems to be a reliable, robust, and user-friendly assay for detection of enzyme-mediated resistance.Keywords
This publication has 20 references indexed in Scilit:
- Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United StatesClinical Infectious Diseases, 2010
- Identification of CTX-M β-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilitiesDiagnostic Microbiology and Infectious Disease, 2010
- AmpC β-LactamasesClinical Microbiology Reviews, 2009
- Rapid Emergence ofblaCTX-MAmong Enterobacteriaceae in U.S. Medical Centers: Molecular Evaluation from the MYSTIC Program (2007)Microbial Drug Resistance, 2008
- First Report of the Emergence of CTX-M-Type Extended-Spectrum β-Lactamases (ESBLs) as the Predominant ESBL Isolated in a U.S. Health Care SystemAntimicrobial Agents and Chemotherapy, 2007
- Carbapenemases: the Versatile β-LactamasesClinical Microbiology Reviews, 2007
- The CTX-M β-lactamase pandemicCurrent Opinion in Microbiology, 2006
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- bla SHV Genes in Klebsiella pneumoniae : Different Allele Distributions Are Associated with Different Promoters within Individual IsolatesAntimicrobial Agents and Chemotherapy, 2005
- Strength and Regulation of the Different Promoters for Chromosomal β-Lactamases of Klebsiella oxytocaAntimicrobial Agents and Chemotherapy, 1999